HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vegt, E. Articles by Oyen, W. J.G. Search for Related Content PubMed PubMed Citation Articles by Vegt, E. Articles by Oyen, W. J.G.

Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin

¹ Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ² Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and ³ Department of Pharmacology and Toxicology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Correspondence: For correspondence or reprints contact: Wim J.G. Oyen, MD, PhD, Department of Nuclear Medicine (444), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: w.oyen{at}nucmed.umcn.nl

Peptide receptor–mediated radiotherapy of neuroendocrine and other somatostatin receptor–positive tumors with radiolabeled somatostatin analogs has been applied in several experimental settings. The kidneys are the organs responsible for dose-limiting toxicity attributable to the retention of radiolabeled octreotide in the renal cortex, leading to a relatively high radiation dose that may result in irreversible loss of kidney function. The administration of basic amino acids reduces renal uptake but does have significant side effects. We observed that gelatin-based plasma expanders induced tubular low-molecular-weight proteinuria in healthy volunteers, suggesting that components in these solutions can interfere with the tubular reabsorption of proteins and peptides. Here, we studied the effects of infusion of low doses of the plasma expander succinylated gelatin (GELO) on the renal uptake of ¹¹¹In-labeled octreotide (¹¹¹In-OCT). Methods: Five healthy volunteers were given ¹¹¹In-OCT, first in combination with normal saline and 2 wk later in combination with GELO. Scintigraphic images of the kidneys as well as blood and urine samples were analyzed. To exclude a nonspecific hemodynamic effect of the plasma expander, the procedure was repeated with 5 other volunteers who received the carbohydrate-based plasma expander hydroxyethyl starch (HES). Results: Low doses of GELO were able to effectively reduce the kidney retention of ¹¹¹In-OCT. The renal radiation dose was significantly reduced by 45% ± 10% (mean ± SD) (P = 0.006), whereas HES showed no significant effect (0% ± 12%). The infusion of GELO did not cause any side effects. Conclusion: GELO effectively reduces the renal uptake of ¹¹¹In-OCT. In contrast to currently used mixtures of amino acids, GELO does not cause any side effects.

Key Words: radiolabeled octreotide • succinylated gelatin • kidneys

Related articles in JNM:

This Month in JNM

JNM 2006 47: 7a-8a. [Full Text]  

This article has been cited by other articles:

				E. Vegt, J. E.M. van Eerd, A. Eek, W. J.G. Oyen, J. F.M. Wetzels, M. de Jong, F. G.M. Russel, R. Masereeuw, M. Gotthardt, and O. C. Boerman Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments J. Nucl. Med., September 1, 2008; 49(9): 1506 - 1511. [Abstract] [Full Text] [PDF]

				S. Bhandari, N. Watson, E. Long, S. Sharpe, W. Zhong, S.-Z. Xu, and S. L. Atkin Expression of Somatostatin and Somatostatin Receptor Subtypes 1-5 in Human Normal and Diseased Kidney J. Histochem. Cytochem., August 1, 2008; 56(8): 733 - 743. [Abstract] [Full Text] [PDF]

				R. M. Sharkey, H. Karacay, W. J. McBride, E. A. Rossi, C.-H. Chang, and D. M. Goldenberg Bispecific Antibody Pretargeting of Radionuclides for Immuno Single-Photon Emission Computed Tomography and Immuno Positron Emission Tomography Molecular Imaging: An Update Clin. Cancer Res., September 15, 2007; 13(18): 5577s - 5585s. [Abstract] [Full Text] [PDF]

				M. Gotthardt, J. van Eerd-Vismale, W. J.G. Oyen, M. de Jong, H. Zhang, E. Rolleman, H. R. Maecke, M. Behe, and O. Boerman Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides J. Nucl. Med., April 1, 2007; 48(4): 596 - 601. [Abstract] [Full Text] [PDF]

				E. J. Rolleman, M. de Jong, R. Valkema, D. Kwekkeboom, B. Kam, and E. P. Krenning Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine? J. Nucl. Med., October 1, 2006; 47(10): 1730 - 1731. [Full Text] [PDF]

				J. E.M. van Eerd, E. Vegt, J. F.M. Wetzels, F. G.M. Russel, R. Masereeuw, F. H.M. Corstens, O. C. Boerman, and W. J.G. Oyen Reply: Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine? J. Nucl. Med., October 1, 2006; 47(10): 1731 - 1731. [Full Text] [PDF]